Imara announces interim analysis data from forte phase 2b clinical trial of tovinontrine (imr-687) in transfusion-dependent subjects with beta-thalassemia

Positive trend observed in transfusion-dependent subjects treated with  higher dose tovinontrine for reduced transfusion burden
ELVN Ratings Summary
ELVN Quant Ranking